Healthcare provider profile · identity verified

Baskar S Duval, MD

Internal Medicine · BILLINGS, MT · NPI 1346289758

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	672	182
Levothyroxine Sodium	Levothyroxine Sodium	653	153
Losartan Potassium	Losartan Potassium	530	145
Amlodipine Besylate	Amlodipine Besylate	496	121
Metoprolol Succinate	Metoprolol Succinate	484	124
Pantoprazole Sodium	Pantoprazole Sodium	373	99
Gabapentin	Gabapentin	338	102
Omeprazole	Omeprazole	322	87
Rosuvastatin Calcium	Rosuvastatin Calcium	308	85
Furosemide	Furosemide	297	83
Lisinopril	Lisinopril	274	74
Tamsulosin Hcl	Tamsulosin Hcl	254	72
Simvastatin	Simvastatin	251	68
Potassium Chloride	Potassium Chloride	237	66
Allopurinol	Allopurinol	226	60
Tramadol Hcl	Tramadol Hcl	215	52
Metformin Hcl Er	Metformin Hcl	176	51
Ozempic	Semaglutide	166	21
Glipizide Er	Glipizide	151	44
Eliquis	Apixaban	150	31
Metformin Hcl	Metformin Hcl	150	41
Trazodone Hcl	Trazodone Hcl	150	36
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	138	40
Jardiance	Empagliflozin	127	31
Citalopram Hbr	Citalopram Hydrobromide	119	29
Warfarin Sodium	Warfarin Sodium	111	30
Spironolactone	Spironolactone	108	29
Celecoxib	Celecoxib	100	32
Donepezil Hcl	Donepezil Hcl	96	25
Sertraline Hcl	Sertraline Hcl	94	28
Carvedilol	Carvedilol	91	30
Meloxicam	Meloxicam	91	31
Pravastatin Sodium	Pravastatin Sodium	90	27
Ezetimibe	Ezetimibe	86	22
Zolpidem Tartrate	Zolpidem Tartrate	84	30
Alendronate Sodium	Alendronate Sodium	78	17
Metoprolol Tartrate	Metoprolol Tartrate	78	25
Montelukast Sodium	Montelukast Sodium	76	19
Fluoxetine Hcl	Fluoxetine Hcl	75	20
Hydrochlorothiazide	Hydrochlorothiazide	71	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	65	22
Duloxetine Hcl	Duloxetine Hcl	64	15
Memantine Hcl	Memantine Hcl	64	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	64	13
Clopidogrel	Clopidogrel Bisulfate	63	22
Mounjaro	Tirzepatide	63	18
Torsemide	Torsemide	61	19
Albuterol Sulfate Hfa	Albuterol Sulfate	60	35
Bupropion Xl	Bupropion Hcl	60	19
Mirtazapine	Mirtazapine	60	19
Finasteride	Finasteride	59	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	59	19
Escitalopram Oxalate	Escitalopram Oxalate	55	15
Oxycodone Hcl	Oxycodone Hcl	55	16
Prednisone	Prednisone	55	38
Ipratropium Bromide	Ipratropium Bromide	52	20
Lorazepam	Lorazepam	52	18
Venlafaxine Hcl Er	Venlafaxine Hcl	49	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	47	15
Doxazosin Mesylate	Doxazosin Mesylate	46	14
Trulicity	Dulaglutide	45	suppressed
Glimepiride	Glimepiride	44	suppressed
Famotidine	Famotidine	42	15
Bupropion Hcl Sr	Bupropion Hcl	40	12
Irbesartan	Irbesartan	40	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	36	suppressed
Alprazolam	Alprazolam	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	16
Nortriptyline Hcl	Nortriptyline Hcl	35	suppressed
Terazosin Hcl	Terazosin Hcl	35	suppressed
Topiramate	Topiramate	35	suppressed
Cephalexin	Cephalexin	34	29
Tizanidine Hcl	Tizanidine Hcl	34	15
Fenofibrate	Fenofibrate,micronized	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	13
Potassium Citrate Er	Potassium Citrate	33	12
Temazepam	Temazepam	33	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Pregabalin	Pregabalin	31	12
Estradiol	Estradiol	30	16
Diclofenac Sodium	Diclofenac Sodium	29	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Baclofen	Baclofen	28	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	20
Xarelto	Rivaroxaban	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Methocarbamol	Methocarbamol	26	15
Methylprednisolone	Methylprednisolone	26	25
Clonidine Hcl	Clonidine Hcl	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	suppressed
Atenolol	Atenolol	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Cefdinir	Cefdinir	22	18
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	16
Valacyclovir	Valacyclovir Hcl	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Azithromycin	Azithromycin	20	13
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	17	17
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Dutasteride	Dutasteride	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Ramipril	Ramipril	15	suppressed
Olanzapine	Olanzapine	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Primidone	Primidone	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error